Posts Tagged ‘Published’

Newly Published Study Finds High Prevalence of BRCA Mutations in Breast Carcinoma in Situ (CIS)

Newly Published Study Finds High Prevalence of BRCA Mutations in Breast Carcinoma in Situ (CIS)
SALT LAKE CITY — Myriad Genetics, Inc. announced today that an article entitled “Prevalence of BRCA1 and BRCA2 Mutations In Women With Carcinoma In Situ of the Breast Referred for Genetic Testing” will appear in the December 2010 issue of the journal Cancer Prevention Research.

Read more on GlobeNewswire via Yahoo! Finance

Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone Complications in Patients With …

Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone Complications in Patients With …
THOUSAND OAKS, Calif., Nov. 8, 2010 /PRNewswire-FirstCall/ — Amgen (Nasdaq: AMGN) today announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa® (zoledronic acid) in delaying or preventing skeletal-related events (SREs) in breast cancer patients with bone metastases. An SRE consists of any of the following: a pathologic fracture …

Read more on redOrbit

Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast Cancer Research

Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast Cancer Research
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer …

Read more on News-Medical-Net

Results from study that identifies genes regulated by ERB published in Journal of Biological Chemistry

Results from study that identifies genes regulated by ERB published in Journal of Biological Chemistry
Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.

Read more on News-Medical-Net

Newly Published Data Shows Chronix Biomedical’s Serum DNA Assays Can Monitor Disease Activity and Treatment Response …

Newly Published Data Shows Chronix Biomedical’s Serum DNA Assays Can Monitor Disease Activity and Treatment Response …
SAN JOSE, Calif.—-Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis .

Read more on Business Wire via Yahoo! Finance

Fran Lenzo Records Daily Battles With Breast Cancer in Self Published Book

Author Fran Lenzo had only known the life she led before she met an Angel named John in 1994. After her holy encounters with the celestial being, she was taught to live each day embracing her mastectomy and breast cancer with the strength and courage she did not know she possessed. Her unyielding character was featured on their local newspaper and drew attention to several other people in small town Long Island.

Reading the book Halo My Dear Angel is like reading someone else’s hatless and wigless state in journal entries. Some chapters of this Xlibris published book are also composed of short stories, essays, or accounts of angel messages that others have also shared to this author who highlighted such experiences with the same character and vein that the people of Long Island has known of her.

This self-published book will make readers appreciate the significance of making the month of October the Breast Cancer Awareness month to help people take charge of their own health. Halo My Dear Angel: a Journey of Miracles will direct readers to that first and most important step.

About Xlibris
Xlibris was founded in 1997 and, as the leading publishing services provider for authors, has helped to publish more than 20,000 titles. Xlibris is based in Philadelphia, PA and provides authors with direct and personal access to quality publication in hardcover, trade paperback, custom leather-bound, and full-color formats.

For more information, please visit www.xlibris.com, e-mail pressrelease@xlibris.com or call at 1-888-795-4247, to receive a free publishing guide.

Positive results from international study of Oncotype DX breast cancer RS published

Positive results from international study of Oncotype DX breast cancer RS published
Genomic Health, Inc. today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX® breast cancer Recurrence Score® (RS) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive, postmenopausal breast cancer patients who are treated with either anastrozole …

Read more on News-Medical-Net

Study Confirming Disparity In Breast Cancer Treatment Published In ‘Cancer’

Study Confirming Disparity In Breast Cancer Treatment Published In ‘Cancer’
Cancer, the peer-reviewed international journal of the American Cancer Society, has published a study conducted by HealthCore, Inc. in its Jan. 1 edition, demonstrating disparities in breast cancer treatment between commercially insured African-American and white women. The HealthCore study reiterates the findings of previous studies – conducted in populations using government health programs …

Read more on Medical News Today